Tech
Anagenex, which combines AI and large-scale proprietary data sets for drug discovery, has raised $30 million in Series A funding led by Catalio Capital Management (Arundhati Parmar/MedCity News)
Arundhati Parmar / News about MedCity:
Anagenex, which combines AI and large-scale proprietary data sets for drug discovery, has raised $30 million Series A led by Catalio Capital ManagementAnagenex CEO believes the company’s AI engine trained on billions of data points and repeated testing will blow away other AI drug discovery startups.
Source link